Back to 
National Bank of Canada
National Bank of Canada
DRUG
Showing 3 of 5 quarters
Position history for National Bank of Canada's holdings in Bright Minds Biosciences Inc.
No. National Bank of Canada exited its DRUG (Bright Minds Biosciences) position in Q1 2025. Its Q4 2024 13F listed 92 shares worth $3,306. National Bank of Canada first reported DRUG in Q1 2024 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$5,802
Total Shares Change
-4,959
Quarter-by-Quarter History